Hsieh TH - Search Results

1

PFDN4 as a Prognostic Marker Was Associated with Chemotherapy Resistance through CREBP1/AURKA Pathway in Triple-Negative Breast Cancer.

Wang SH, Yeh CH, Wu CW, Hsu CY, Tsai EM, Hung CM, Wang YW, Hsieh TH. Wang SH, et al. Among authors: hsieh th. Int J Mol Sci. 2024 Mar 31;25(7):3906. doi: 10.3390/ijms25073906. Int J Mol Sci. 2024. PMID: 38612711 Free PMC article.

2

Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway.

Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, Wang SC, Tsai EM. Hsieh TH, et al. FASEB J. 2012 Feb;26(2):778-87. doi: 10.1096/fj.11-191742. Epub 2011 Nov 2. FASEB J. 2012. PMID: 22049059

3

miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis.

Hsieh TH, Hsu CY, Tsai CF, Long CY, Chai CY, Hou MF, Lee JN, Wu DC, Wang SC, Tsai EM. Hsieh TH, et al. Oncotarget. 2015 Jan 1;6(1):494-509. doi: 10.18632/oncotarget.2674. Oncotarget. 2015. PMID: 25504437 Free PMC article.

4

HDAC inhibitors target HDAC5, upregulate microRNA-125a-5p, and induce apoptosis in breast cancer cells.

Hsieh TH, Hsu CY, Tsai CF, Long CY, Wu CH, Wu DC, Lee JN, Chang WC, Tsai EM. Hsieh TH, et al. Mol Ther. 2015 Apr;23(4):656-66. doi: 10.1038/mt.2014.247. Epub 2014 Dec 22. Mol Ther. 2015. PMID: 25531695 Free PMC article.

5

KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.

Tang FH, Hsieh TH, Hsu CY, Lin HY, Long CY, Cheng KH, Tsai EM. Tang FH, et al. Among authors: hsieh th. Int J Cancer. 2017 Apr 15;140(8):1860-1869. doi: 10.1002/ijc.30591. Int J Cancer. 2017. PMID: 28032649

6

Estradiol induces cell proliferation in MCF‑7 mammospheres through HER2/COX‑2.

Wu CH, Chuang HY, Wang CL, Hsu CY, Long CY, Hsieh TH, Tsai EM. Wu CH, et al. Among authors: hsieh th. Mol Med Rep. 2019 Mar;19(3):2341-2349. doi: 10.3892/mmr.2019.9879. Epub 2019 Jan 18. Mol Med Rep. 2019. PMID: 30664162

7

DEHP mediates drug resistance by directly targeting AhR in human breast cancer.

Hsieh TH, Hsu CY, Yang PJ, Chiu CC, Liang SS, Ou-Yang F, Kan JY, Hou MF, Wang TN, Tsai EM. Hsieh TH, et al. Biomed Pharmacother. 2022 Jan;145:112400. doi: 10.1016/j.biopha.2021.112400. Epub 2021 Nov 18. Biomed Pharmacother. 2022. PMID: 34801851 Free article.

8

Effects of Luteolin on Human Breast Cancer Using Gene Expression Array: Inferring Novel Genes.

Wang SH, Wu CH, Tsai CC, Chen TY, Tsai KJ, Hung CM, Hsu CY, Wu CW, Hsieh TH. Wang SH, et al. Among authors: hsieh th. Curr Issues Mol Biol. 2022 May 9;44(5):2107-2121. doi: 10.3390/cimb44050142. Curr Issues Mol Biol. 2022. PMID: 35678671 Free PMC article.

9

Venetoclax Decreases the Expression of the Spike Protein through Amino Acids Q493 and S494 in SARS-CoV-2.

Chen CC, Zhuang ZJ, Wu CW, Tan YL, Huang CH, Hsu CY, Tsai EM, Hsieh TH. Chen CC, et al. Among authors: hsieh th. Cells. 2022 Jun 14;11(12):1924. doi: 10.3390/cells11121924. Cells. 2022. PMID: 35741053 Free PMC article.

10

Vorinostat decrease M2 macrophage polarization through ARID1A^6488delG/HDAC6/IL-10 signaling pathway in endometriosis-associated ovarian carcinoma.

Hsieh TH, Hsu CY, Wu CW, Wang SH, Yeh CH, Cheng KH, Tsai EM. Hsieh TH, et al. Biomed Pharmacother. 2023 May;161:114500. doi: 10.1016/j.biopha.2023.114500. Epub 2023 Mar 21. Biomed Pharmacother. 2023. PMID: 36958195 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters